Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

Journal of Clinical Oncology

Volumn 28, Issue 1, 2010, Pages 126-131

  Klotz, Laurence ^a   Zhang, Liying ^a   Lam, Adam ^a   Nam, Robert ^a   Mamedov, Alexandre ^a   Loblaw, Andrew ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; WATCHFUL WAITING; BLOOD; MORTALITY; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; STATISTICAL MODEL;

AGED; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 73949130115     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.2180     Document Type: Article

References (18)

1. Franks LM: Proceedings: Etiology, epidemiology, and pathology of prostatic cancer. Cancer 32: 1092-1095, 1973
2. Hølund B: Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol 14:29-35, 1980
3. Canadian Cancer Statistics 2000. National Cancer Institute of Canada, Toronto, Canada, 2001
4. Schröder FH, Hugosson J, Roobol MJ, et al: Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320-1328, 2009
5. Choo R, Klotz L, Danjoux C, et al: Feasibility study: Watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 167:1664-1669, 2002
6. Klotz L: Active surveillance for prostate cancer: For whom? J Clin Oncol 23:8165-8169, 2005
7. Remzi M, Fong YK, Dobrovits M, et al: The Vienna nomogram: Validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol 174:1256-1260, 2005
8. Fryback DG, Albertsen PC, Storer BE: Prostatectomy and survival among men with clinically localized prostate cancer. JAMA 276:1723-1724, 1996
9. Zhang L, Loblaw A, Klotz L: Modeling prostate specific antigen kinetics in patients on active surveillance. J Urol 176:1392-1397, 2006; discussion 1397-1398
10. van As NJ, Norman AR, Thomas K, et al: Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol 54:1297-1305, 2008
11. Carter HB, Kettermann A, Warlick C, et al: Expectant management of prostate cancer with curative intent: An update of the Johns Hopkins experience. J Urol 178:2359-2364, 2007
12. Soloway MS, Soloway CT, Williams S, et al: Active surveillance: A reasonable management alternative for patients with prostate cancer-The Miami experience. BJU Int 101:165-169, 2008
13. van den Bergh RC, Roemeling S, Roobol MJ, et al: Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol [e-pub ahead of print on September 17, 2008]
14. Khatami A, Aus G, Damber JE, et al: PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section. Int J Cancer 120:170-174, 2007
15. Fleming C, Wasson JH, Albertsen PC, et al: A decision analysis of alternative treatment strategies for clinically localized prostate cancer: Prostate Patient Outcomes Research Team. JAMA 269:2650-2658, 1993
16. Wasson JH, Cushman CC, Bruskewitz RC, et al: A structured literature review of treatment for localized prostate cancer: Prostate Disease Patient Outcome Research Team. Arch Fam Med 2:487-493, 1993
17. Johansson JE: Expectant management of early stage prostatic cancer: Swedish experience. J Urol 152:1753-1756, 1994
18. Johansson JE, Andrén O, Andersson S, et al: Natural history of early, localized prostate cancer. JAMA 291:2713-2719, 2004